When we investigated the IFN-γ inducible chemokines, we found no differences in CXCL9 and -10 levels between groups, but both MPN groups had higher levels of CXCL11 than the two AMD groups. This evidence concerns the gene CXCL11 and myeloproliferative neoplasm.